5Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol, 2005,40(2) :90-97.
6Martin LW, Correa AM, Ordonez NG, et al. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg, 2007 84 (3) : 973-980.
7Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid turnouts: revised RECIST guideline ( version 1.1 ). Eur J Cancer, 2009 45 (2) 228-247.
8Pelosi G, Sonzogni A, De Pas T, et al. Review article: pulmonary sarcomatoid earcinomas:a practical overview. Int J Surg Pathol,2010; 18(2) : 103-120.
9Kaira K, Horie Y, Ayabe E, et al. Pulmonary pleomorphic carcinoma:a clinicopathological study including EGFR mutation analysis. J Thorac Oncol,2010;5(4) :460-465.
10Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N EnglJ Med,2002;346(2):92-98.
